Moderna shares surge over 560%, but Wall Street deems them overvalued
MRNA Moderna Inc
$225.00 +14.21%
View chart & analysis → - 1Moderna shares have recorded a gain of over 560% this year.
- 2Moderna's second-quarter revenue reached $145 million.
- 3A 38% probability of a decline for Moderna at current levels has been raised.
So what's the key point?
Moderna's stock price has risen by more than 560% this year. However, there is a 38% chance that the price could fall because the stock is considered too expensive.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.